Pascal Lenain

5.0k citations
89 papers · 4.0k · 1 hit paper · h-index 27

Impact in

  • Hematology top 0.2%
    • Multiple Myeloma Research and Treatments
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 2%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Multiple Myeloma Research and Treatments 38
    • Chronic Myeloid Leukemia Treatments 16
    • Chronic Lymphocytic Leukemia Research 17

Pascal Lenain

86 papers receiving 3.8k citations

Pascal Lenain's Hit Papers

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study 2019 · 769 citations
7690+2+4Years since publication250500750

Peers

Pascal Lenain
Comparison fields: 5 of 89
  • Hematology 2.9k
  • Genetics 678
  • Oncology 1.6k
  • Pathology and Forensic Medicine 593
  • Molecular Biology 1.8k
Replace Mehmet Turgut with:
Mehmet Turgut Türkiye
Dina Ben Yehuda Israel
Antonietta Pia Falcone Italy
Eileen Mary Boyle United States
Mieczysław A. Komarnicki Poland
Donna M. Weber United States
Sherry A. Pierce United States
J. Anthony Child United Kingdom
Eirini Katodritou Greece
Brigitte Kolb France
Pascal Lenain relative to Mehmet Turgut Türkiye Mehmet Turgut's profile →
Citations per field
00.5×2×3×3.9×
Mehmet Turgut · 1×
Citations per year

Countries citing papers authored by Pascal Lenain

Since Specialization
Citations

This map shows the geographic impact of Pascal Lenain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Lenain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Lenain more than expected).

Fields of papers citing papers by Pascal Lenain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Lenain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Lenain. The network helps show where Pascal Lenain may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Lenain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Lenain Line = papers co-authored together Pascal Lenain links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Hit paper breakdown →
2019769
2 2010461
3 2009328
4 2011265
5 2016224
6 2009136
7
patients with the description of a new scoring system and its validation on 253 other patients.
2000119
8 2014116
9 2010114
10 201998
11 201885
12 200682
13 202074
14 200068
15 200268
16 200059
17 201659
18 201852
19 201545
20 200243

About Pascal Lenain

Pascal Lenain is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Rheumatology, having authored 89 papers that have together received 4.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (38 papers), Chronic Lymphocytic Leukemia Research (17 papers), Chronic Myeloid Leukemia Treatments (16 papers), Protein Degradation and Inhibitors (15 papers), Cancer Treatment and Pharmacology (15 papers), Lymphoma Diagnosis and Treatment (13 papers), Eosinophilic Disorders and Syndromes (11 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Hematology (2.9k citations), Genetics (678 citations), Oncology (1.6k citations), Pathology and Forensic Medicine (593 citations) and Molecular Biology (1.8k citations). Pascal Lenain has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Thierry T.F. Facon, Claire Mathiot, Philippe Moreau, Philippe Casassus, Lotfi Benboubker, Stéphane Leprêtre, Aspasia Stamatoullas, Gérard Buchonnet, Christian Bastard and Hervé Tilly. Their work appears in journals such as Blood, Leukemia, Haematologica, Bone Marrow Transplantation and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact